Core Viewpoint - The Federal Reserve is maintaining a cautious stance regarding interest rate cuts due to concerns over inflationary pressures from tariffs imposed by President Trump, leading to uncertainty in the market [1][5][6]. Federal Reserve Meeting Insights - The minutes from the latest Federal Reserve meeting indicate that most officials are not in a hurry to implement an immediate rate cut, suggesting a wait-and-see approach [2][5]. - A delay in rate cuts could lead to increased volatility in the stock market [2][7]. - Most participants believe that any inflationary impact from tariffs will be temporary or modest, and there is no urgency for rate cuts in the near term [6]. Investment Recommendations - Given the current uncertainty, it is advisable to invest in defensive stocks from the utility and consumer staples sectors, which are considered safe havens [3][11]. - Recommended stocks include: - **Atmos Energy Corporation (ATO)**: Expected earnings growth rate of 6%, Zacks Rank 2, beta of 0.70, and a dividend yield of 2.27% [9]. - **Fortis, Inc. (FTS)**: Expected earnings growth rate of 3.8%, Zacks Rank 2, beta of 0.48, and a dividend yield of 3.81% [13]. - **Colgate-Palmolive Company (CL)**: Expected earnings growth rate of 1.7%, Zacks Rank 2, beta of 0.37, and a dividend yield of 2.27% [15]. - **The Coca-Cola Company (KO)**: Expected earnings growth rate of 3.1%, Zacks Rank 2, beta of 0.45, and a dividend yield of 2.94% [17]. Stock Characteristics - The recommended stocks are characterized by low beta (greater than 0 but less than 1), high dividend yields, and favorable Zacks Ranks, making them attractive in the current market environment [4][11].

证券研究报告 | 2025年07月11日 时代新材（600458.SH） 重点布局新材料业务矩阵，有望打造新利润增长点 公司研究·公司快评 电力设备·风电设备 投资评级：优于大市（维持） 证券分析师： 王蔚祺 010-88005313 wangweiqi2@guosen.com.cn 执证编码：S0980520080003 证券分析师： 王晓声 010-88005231 wangxiaosheng@guosen.com.cn 执证编码：S0980523050002 证券分析师： 袁阳 0755-22940078 yuanyang2@guosen.com.cn 执证编码：S0980524030002 事项： 日前公司宣布第四大业务板块新材料事业部完成业务矩阵布局。公司 2023 年末开启建设新材料产业园&中 试基地，主要生产高端聚氨酯减振及防护制品、有机硅 PACK 功能材料以及 HP-RTM PACK（高压树脂传递模 塑）结构材料，基于多年经验积累，不断拓展新材料产品序列。目前成功形成覆盖聚氨酯、有机硅、HP-RTM 以及芳纶材料的产品矩阵，并积极研制 PI 光电信息材料、PAI 聚酰胺酰亚胺、可回收环氧树脂 ...

北京时间7月11日凌晨3点，比特币强势突破116,500美元大关，24小时交易量激增48% • 链上数据显示，巨鲸地址近一周增持超2.3万枚BTC，机构持仓量创年内新高 • 衍生品市场未平仓合约突破380亿美元，市场情绪指数进入"极度贪婪"区间 牛市背后的三大核心逻辑： 货币政策转向 美联储点阵图显示年内或降息50个基点 美国10年期国债收益率跌破4.2%关键支撑位 美元指数DXY周线三连阴，资金加速流向风险资产 制度性突破 贝莱德比特币ETF单周净流入达8.7亿美元 摩根大通推出机构级数字资产托管方案 香港证监会批准首批虚拟资产现货ETF 技术创新共振 以太坊L2总锁仓量突破450亿美元 AI+区块链项目融资额Q2环比增长215% 模块化区块链架构获得主流机构认可 山寨币季节的财富密码 历史数据揭示牛市演进规律： 第一阶段：比特币独涨（已完成） 第二阶段：主流币补涨（进行中） 第三阶段：优质山寨币爆发（即将到来） 当前市场正在筛选具备以下特质的alpha项目： 市值1-5亿美元区间 日交易量稳定在3000万美元以上 具备真实营收场景 机构持仓占比超过15% DHP：RWA赛道的现象级项目 【核心优势矩阵】 ...

点击招商研究小程序查看PDF报告原文 参考报告： 1、《沪电股份（002463）—20年业绩符合预期，青淞厂开启新一轮扩产计划》2021/02/03 2、《沪电股份（002463）—入股胜伟策，长线卡位汽车板下一代技术》2022/01/12 3、《沪电股份（002463）—今年有望迎增长拐点，汽车+数通长线逻辑清晰》2022/03/24 4、《沪电股份（002463）—Q1迎来经营拐点，疫情担忧不改长期趋势》2022/04/25 5、《沪电股份（002463）—H1业绩逆势增长，创新需求持续驱动产品产能结构升级》2022/08/24 6、《沪电股份（002463）—Q3业绩稳中向好，源于产品结构升级、稼动率提升及汇兑收益》2022- 10-25 7、《沪电股份（002463）点评报告—Q4业绩优于市场预期，数通及汽车板仍为成长主线》2023- 02-01 8、《沪电股份（002463）点评报告—盈利能力持续改善，数通+汽车双轮驱动打开长线空间》 2023-03-24 9、《沪电股份（002463）—Q1业绩短期承压，AI算力+汽车打开长线增长空间》2023-04-26 10、《沪电股份（002463）：Q2业 ...

Group 1 - The 2025 CPHI World Pharmaceutical Raw Materials Exhibition in Shanghai was successfully held, featuring an unprecedented scale with 3600 participating companies and over 30,000 overseas buyers from 147 countries [1] - Pharma United Co., Ltd. showcased its innovative products at the exhibition, highlighting its leadership in the cleanroom industry [1][2] Group 2 - Pharma United's HPL (High-Pressure Laminate) board was presented, demonstrating its superior performance in pharmaceutical applications, including high strength, wear resistance, and antibacterial properties, which help reduce contamination risks [2][3] - The company’s modular cleanroom models showcased its capabilities in cleanroom construction, emphasizing a 70% reduction in construction time compared to traditional methods [3] Group 3 - The exhibition included interactive areas that enhanced engagement, such as a coffee station and a dart game zone, fostering a lively atmosphere for networking [4] - Pharma United has been actively participating in CPHI exhibitions since its establishment in 2006, building a strong industry reputation and resource network [4] - The event served as a platform for industry discussions on cutting-edge technologies and market trends, laying a foundation for future collaborations [4]

Group 1 - Chengdu High-tech Zone Medical Device Innovation and Transformation Association facilitated Qinglan Jichuang Medical Equipment to obtain a credit line of tens of millions from Chengdu Bank, specifically for production line expansion and technology research and development [1] - Anbiping announced that its HPV nucleic acid test kit received a medical device registration certificate from the National Medical Products Administration, capable of detecting 18 high-risk HPV types and further expanding its layout in the tumor screening field [1] - In the first half of 2025, China approved 45 innovative medical devices, a year-on-year increase of 87%, reflecting the continuous policy dividends driving industry technological upgrades [1] Group 2 - The domestic nuclear medicine industry has a high dependence on imported radionuclide raw materials, but domestic technological breakthroughs and capacity releases are expected to enhance the self-supply capability of major isotopes [2] - The nuclear medicine regulatory environment is strict, creating high barriers to entry, with companies like China Radiopharmaceuticals and Dongcheng Pharmaceutical holding a first-mover advantage in the midstream production and distribution sectors [2] - The nuclear medicine market is projected to grow at a compound annual growth rate of over 20% over the next five years, reaching 26 billion yuan by 2030, driven by policy support and increasing medical resource allocation [2] Group 3 - The ChiNext Medical ETF tracks the Chuangyi Medicine Index, which can experience daily fluctuations of up to 20%, reflecting the overall performance of listed companies in the medical manufacturing, medical devices, and medical services sectors on the ChiNext market [2] - The index consists of companies with innovative characteristics and high growth potential, generally characterized by high research and development investment and industry development potential [2]

证券研究报告 | 公司点评报告 2025 年 07 月 11 日 % 1m 6m 12m 绝对表现 30 8 14 相对表现 26 0 -3 资料来源：公司数据、招商证券 -60 -40 -20 0 20 40 Jul/24 Nov/24 Feb/25 Jun/25 (%) 沪电股份 沪深300 相关报告 沪电股份（002463.SZ） Q2 业绩超预期，拟加码黄石基地扩产，看好中长线 AI 订单承接能力 TMT 及中小盘/电子 事件：1）公司发布 2025 年业绩预告。2）公司近期公告同意出于黄石沪士未 来经营发展的需求，2025 年 7 月至 2031 年 6 月期间，在不超过人民币 36 亿 元的总投资额度范围内，授权管理层可就潜在项目投资与黄石经济技术开发区 管理委员会进行磋商。我们点评如下： 强烈推荐（维持） 当前股价：47.25 元 基础数据 | 总股本（百万股） | 1923 | | --- | --- | | 已上市流通股（百万股） | 1922 | | 总市值（十亿元） | 90.9 | | 流通市值（十亿元） | 90.8 | | 每股净资产（MRQ） | 6.6 | | ROE（TTM） ...

Group 1 - The core viewpoint of the news highlights the support for innovation in the medical device industry, with significant funding and regulatory approvals driving growth [1][2] - Chengdu High-tech Zone Medical Device Innovation and Transformation Association assisted a startup in obtaining a credit line in the millions from Chengdu Bank, aimed at expanding production lines and technology research [1] - The National Medical Products Administration (NMPA) reported that 45 innovative medical devices were approved in the first half of 2025, representing a year-on-year increase of 87%, indicating ongoing policy benefits for industry innovation [1] Group 2 - Everbright Securities pointed out that the NMPA's announcement supports the innovation of high-end medical devices, including medical robots, advanced imaging equipment, AI medical devices, and new biomaterials [2] - The document emphasizes the expectation of faster commercialization of innovative medical devices under policy support, with a comprehensive standard system gradually being established for product design, production quality control, and post-market supervision [2] - The document also supports the international development of high-end medical device companies, which is expected to promote standardization and internationalization in the industry, benefiting leading companies with strong R&D capabilities and scalable products [2]

Core Viewpoint - Burcon NutraScience Corporation is set to showcase its innovative Chipotle Black Bean Protein Hummus at the IFT FIRST Annual Event & Expo, highlighting its advancements in plant-based protein technology [1][6]. Group 1: Product Innovation - The Chipotle Black Bean Protein Hummus is crafted using Burcon's proprietary triple blend of Peazazz®C pea protein, Puratein®C canola protein, and Solatein™ sunflower protein, resulting in a dip that is both flavorful and nutritious [6][8]. - Burcon's plant-based proteins boast over 90% purity, neutral flavor, and smooth mouthfeel, making them suitable for various food applications [6][9]. Group 2: Event Details - The IFT FIRST event will take place in Chicago from July 13-16, 2025, where Burcon will be located at booth S4066 [1][6]. - Attendees will have the opportunity to sample the Chipotle Black Bean Protein Hummus during a special tasting event on July 14 and 15, from 11:00 AM to 1:00 PM [7][9]. Group 3: Company Background - Burcon NutraScience is recognized as a global leader in high-performance plant-based proteins, with a strong commitment to sustainability and innovation in the food and beverage industry [11]. - The company holds an extensive patent portfolio covering novel proteins derived from various plant sources, positioning itself as a key player in the growing plant-based market [11].

In July, LetsBonk has captured 75% of launchpad token graduations on Solana https://t.co/7auHtMiWvY ...